Abstract:Background It is unclear whether high‐sensitivity troponin T (hs‐TnT) is associated with subclinical cardiac changes in chronic kidney disease (CKD). We evaluated the relationship between hs‐TnT and left ventricular structure and function in a CKD population, according to estimated glomerular filtration rate. Methods and Results We analyzed 2017 patients with CKD stages 1 to 5 (predialysis) in the KNOW‐CKD (Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease) cohort. The predictor was hs‐TnT level measured at baseline, and the outcomes were left ventricular hypertrophy (LVH) and systolic and diastolic dysfunction shown by echocardiography at baseline and after 4 years. Participants were categorized into quartiles according to hs‐TnT levels. The associations between quartiles of hs‐TnT and outcomes were assessed using multivariable logistic regression analysis with confounders including demographics, medical history, and laboratory findings. A receiver operating characteristic curve was used to assess the diagnostic power of hs‐TnT for the outcomes as a continuous variable. For subgroup analysis, patients were stratified based on an estimated glomerular filtration rate of 60 mL/min per 1.73 m 2 . Elevated hs‐TnT was associated with LVH and diastolic dysfunction at baseline in an adjusted model but was not associated with systolic dysfunction. These associations remained significant for both estimated glomerular filtration rate subgroups. Receiver operating characteristic curve analysis showed that hs‐TnT as a continuous variable exhibited fair significance for detection of LVH (area under the curve: 0.689) and diastolic dysfunction (area under the curve: 0.744). Multivariable analysis showed that higher hs‐TnT levels at baseline were related to development of LVH but not diastolic dysfunction (n=864). Conclusions In CKD patients, hs‐TnT is strongly associated with alterations of left ventricular structure and diastolic dysfunction for both estimated glomerular filtration rate strata. Baseline hs‐TnT levels are predictive of new LVH on follow‐up. Clinical Perspective What Is New? In patients with chronic kidney disease, high‐sensitivity troponin T (TnT) is strongly associated with alterations of left ventricular structure and diastolic dysfunction, regardless of estimated glomerular filtration rate strata. Baseline levels of high‐sensitivity TnT are predictive of new left ventricular hypertrophy on follow‐up. What Are the Clinical Implications? This research suggests that a high‐sensitivity TnT assay could be a useful targeted strategy for risk stratification of patients who may need further cardiac evaluation, regardless of renal function. Further studies are needed to confirm the ideal cutoff values for high‐sensitivity TnT in chronic kidney disease. Introduction Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). It is important to identify risk factors for prevention of cardiovascular disease in patients with CKD to facilitate treatment in the asymptomatic phase. Although pathologic changes in cardiac structure including left ventricular hypertrophy (LVH) may affect cardiovascular mortality, 1 , 2 they do not produce definite cardiac symptoms. For these reasons, physicians and researchers have invested considerable effort into identifying biomarkers related to subclinical changes in cardiac structure. The conventional cardiac troponin T (TnT) assay has become a widely used biomarker for diagnosing acute coronary syndrome. 3 Troponin assays have continued to evolve, and a high‐sensitivity TnT (hs‐TnT) assay with detection limits 10 to 100 times lower than conventional assays is now available. Importantly, hs‐TnT can be detected in asymptomatic patients with no history of cardiovascular disease. Chronically elevated levels of hs‐TnT were recently shown to be associated with chronic subclinical myocardial damage in the general population, including left ventricular (LV) structure abnormalities. 4 , 5 , <a class="tab-link" href="#jah34438-bib-000 -Abstract Truncated-

Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population‐based cohorts: the BiomarCaRE project

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)

Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction

Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance

Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation

High-Sensitivity Cardiac Troponin T Assessment to Improve Cardiovascular Risk Prognostication in Patients with Chronic Kidney Disease: Ready for Prime Time?

Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.

Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database

Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study

A Study of Abnormal Echocardiogram Findings in Patients With Chronic Kidney Disease With Reference to Cardiac Biomarkers

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction

Association of cardiac troponin T with left ventricular structure and function in CKD

Cardiac Biomarkers are Associated with Incident Fracture Risk in Advanced Chronic Kidney Disease

Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

Plasma Biomarkers as Risk Factors for Incident CKD

NT-proBNP and Stem Cell Factor Plasma Concentrations Are Independently Associated with Cardiovascular Outcomes in End-Stage Renal Disease Hemodialysis Patients.